Absci Corporation (ABSI) Q1 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

2025 Business Update and Financial and Operating Results conference call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 1 1 on your telephone. To remove yourself from the queue, you may press star 1 1 again. I would now like to hand the call over to Alex Khan, VP, Finance and Investor Relations. Please go ahead. Thank you. Earlier today, AdSci released financial and operating results for the quarter ended March 31, 2025. If you haven't received this news release, or if you would like to be added to the company's distribution list, please send an email to investors at AdSci.com. An archived webcast of this call will be available for replay on Abcide's investor relations website at investors.abcide.com for at least 90 days after this call. Joining me today are Sean McLean, Abcide's founder and CEO, and Zach Jonason, Chief Financial Officer and Chief Business Officer. Christian Stegman, Abcide's SVP of Drug Creation, will also join for Q&A following prepared remarks. Before we begin, I'd like to remind you that management will make statements during this call that are forward-looking within the meaning of the federal securities laws. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated, and you should not place undue reliance on forward-looking statements. Additional information regarding these risks, uncertainties, and factors that could cause results to differ appears in the section titled Forward-Looking Statements in the Press Release ABSA Issued Today and the documents or reports filed by ABSA from time to time with Securit...